SYNTARA LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.015 AUD | -11.76% |
|
-11.76% | -25.00% |
| Apr. 10 | Syntara Reaches 50% Recruitment in Phase 2 Trial for Bone Marrow Cancer Treatment | MT |
| Feb. 29 | Syntara Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 100.6 | 26.09 | 40.3 | 35.69 | 35.26 | 17.91 | - | - |
| Enterprise Value (EV) 1 | 76.6 | 19.48 | 27.91 | 26.75 | 26.03 | 10.71 | 8.709 | 14.41 |
| P/E ratio | -5.1 x | -1.89 x | -12.7 x | -16.1 x | -2.45 x | -1.36 x | -1.67 x | -5 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 8.26 x | 2.06 x | 1.7 x | 2.24 x | 1.83 x | 1.54 x | 4.97 x | 3.98 x |
| EV / Revenue | 6.29 x | 1.54 x | 1.18 x | 1.68 x | 1.35 x | 0.92 x | 2.42 x | 3.2 x |
| EV / EBITDA | -4.89 x | -1.61 x | -124 x | -2.61 x | -3.21 x | -1.39 x | -0.68 x | -3.6 x |
| EV / FCF | -3.69 x | -1.41 x | 11.5 x | -1.65 x | - | -1.88 x | -0.84 x | -3.43 x |
| FCF Yield | -27.1% | -71.2% | 8.7% | -60.4% | - | -53.2% | -119% | -29.1% |
| Price to Book | - | - | - | 3.3 x | 3.69 x | - | - | - |
| Nbr of stocks (in thousands) | 394,316 | 395,249 | 452,824 | 549,078 | 719,584 | 1,193,943 | - | - |
| Reference price 2 | 0.2550 | 0.0660 | 0.0890 | 0.0650 | 0.0490 | 0.0150 | 0.0150 | 0.0150 |
| Announcement Date | 7/25/19 | 7/31/20 | 7/28/21 | 7/29/22 | 8/28/23 | - | - | - |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 12.17 | 12.66 | 23.68 | 15.91 | 19.31 | 11.6 | 3.6 | 4.5 |
| EBITDA 1 | -15.65 | -12.08 | -0.225 | -10.25 | -8.114 | -7.7 | -12.8 | -4 |
| EBIT 1 | -18.27 | -15.32 | -3.377 | -13.48 | -9.962 | -8.1 | -13.2 | -4.4 |
| Operating Margin | -150.11% | -120.93% | -14.26% | -84.74% | -51.6% | -69.83% | -366.67% | -97.78% |
| Earnings before Tax (EBT) 1 | - | - | - | -1.93 | -11.36 | -8.2 | -13.3 | -4.5 |
| Net income 1 | -20.06 | -13.94 | -2.97 | -1.93 | -11.36 | -8.2 | -13.3 | -4.5 |
| Net margin | -164.8% | -110.09% | -12.54% | -12.13% | -58.84% | -70.69% | -369.44% | -100% |
| EPS 2 | -0.0500 | -0.0350 | -0.007000 | -0.004030 | -0.0200 | -0.0110 | -0.009000 | -0.003000 |
| Free Cash Flow 1 | -20.78 | -13.86 | 2.428 | -16.17 | - | -5.7 | -10.4 | -4.2 |
| FCF margin | -170.73% | -109.42% | 10.26% | -101.6% | - | -49.14% | -288.89% | -93.33% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 7/25/19 | 7/31/20 | 7/28/21 | 7/29/22 | 8/28/23 | - | - | - |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: June | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2023 Q2 | 2023 S2 |
|---|---|---|---|---|---|---|
| Net sales | 4.021 | 8.644 | 13.69 | 9.989 | - | 10.15 |
| EBITDA | -7.999 | -4.081 | 0.713 | -0.938 | - | - |
| EBIT | -9.615 | -5.701 | -0.876 | -2.501 | - | - |
| Operating Margin | -239.12% | -65.95% | -6.4% | -25.04% | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - |
| Net income 1 | -10.32 | -3.624 | 0.046 | -3.016 | -4.786 | - |
| Net margin | -256.63% | -41.93% | 0.34% | -30.19% | - | - |
| EPS 2 | - | - | - | -0.007000 | -0.000100 | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 1/31/20 | 7/31/20 | 1/29/21 | 7/28/21 | 2/10/23 | 8/28/23 |
1AUD in Million2AUD
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 24 | 6.61 | 12.4 | 8.94 | 9.23 | 7.2 | 9.2 | 3.5 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -20.8 | -13.9 | 2.43 | -16.2 | - | -5.7 | -10.4 | -4.2 |
| ROE (net income / shareholders' equity) | - | - | - | - | -112% | - | - | - |
| ROA (Net income/ Total Assets) | -39% | -31.7% | -8.61% | -6.57% | -46.2% | - | - | - |
| Assets 1 | 51.38 | 44.04 | 34.5 | 29.39 | 24.61 | - | - | - |
| Book Value Per Share | - | - | - | 0.0200 | 0.0100 | - | - | - |
| Cash Flow per Share 2 | - | - | - | -0.0300 | -0.0100 | -0.0100 | -0.0100 | -0 |
| Capex 1 | 0.58 | 0.26 | 0.33 | 0.07 | 0.14 | 0.1 | 0.1 | - |
| Capex / Sales | 4.73% | 2.05% | 1.4% | 0.41% | 0.71% | 0.86% | 2.78% | - |
| Announcement Date | 7/25/19 | 7/31/20 | 7/28/21 | 7/29/22 | 8/28/23 | - | - | - |
1AUD in Million2AUD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -25.00% | 11.75M | |
| +26.47% | 664B | |
| +26.74% | 567B | |
| -6.33% | 354B | |
| +19.35% | 330B | |
| +4.23% | 286B | |
| +13.43% | 234B | |
| +4.71% | 199B | |
| -9.53% | 196B | |
| -4.04% | 148B |
- Stock Market
- Equities
- SNT Stock
- Financials Syntara Limited
